SecBot SecBot
Insider Cluster (5 insiders) ·Filed Jun 3, 2026

OTLK

Outlook Therapeutics, Inc.
BULLISH
Impact 7/10
Horizonweeks Processed5mo ago
Insider cluster: 5 insiders, $5.3M total
Actionable Insight ▲ Bullish

The massive insider purchase by the 10% owner at the offering price signals strong conviction despite the going-concern warning. Monitor for further insider buying or a reverse split/restructuring announcement. The stock may re-rate if the market interprets this as a vote of confidence, but the fundamental cash runway risk remains acute.

DirectionBullish
Confidencemedium
Horizonweeks

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$0.7950
T+0 close · Jun 3, 2026 · via day close
Latest settled
−18.88%
T+60 · $0.6449
Vs SPY
−20.76%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 4 $0.7950entry
  2. T+1 · 6mo ago −2.30%α +0.27% · $0.7767
  3. T+5 · 5mo ago +38.36%α +40.92% · $1.10
  4. T+20 · 4mo ago +82.39%α +83.76% · $1.45
  5. T+60 · 3mo ago −18.88%α −20.76% · $0.6449
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

A significant insider buying cluster at Outlook Therapeutics, totaling $5.25M in open-market purchases, is dominated by a $5.0M purchase by Director and 10% Owner Ghiath M. Sukhtian. This buying occurred just days after the company completed a dilutive $4.9M offering and concurrently amended warrants, raising going-concern doubts. The cluster's size (4.6% of market cap) is highly material and suggests insiders see value despite the distressed capital structure.

Key Financial Metrics

Direction
buying
Total Value
$5.3M
Insiders
5

Key Facts

  • Total insider purchases of $5.25M, representing ~4.6% of OTLK's $114M market cap.
  • Ghiath M. Sukhtian (Director, 10% Owner) purchased 8,539,709 shares at $0.5855 for $5.0M on May 28, 2026.
  • The purchase coincided with a $4.9M registered direct offering at $0.5855 per share, in which Sukhtian was the sole investor.
  • Other directors (Hilzinger, Thurman, Sukhtian Faisal, Haddadin) bought smaller amounts at prices between $0.41 and $0.83.
  • The company has substantial doubt about its ability to continue as a going concern, with cash runway only into September 2026.
  • Cross-filing context includes a 424B5 offering filed 5 days prior, and all calibration amplifiers fire, supporting an elevated impact score.

Financial Impact

Insider purchases of $5.25M represent 4.6% of market cap, a highly material signal. The $5.0M purchase by Sukhtian is effectively the entire offering size, indicating insider alignment with the capital raise.

dilutioncash runwayinsider ownership

Risk Factors

  • Going-concern risk: cash only expected to sustain operations into September 2026.
  • Dilution from the 8.5M share offering and warrant amendments could pressure the stock.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
78% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-OTLK-1780524225768

Track record

37 reports on OTLK

Performance horizon

12 of 22 bullish or bearish reports moved the stock their way by T+5. Best: +306.25% at T+20 after the May 26, 2026 report. 17 of 22 went positive at some point.

Filters
  1. Oct 13, 20264w ago SC 13G Neutral 4/10 Entry $0.5638 to $0.5200 Now $0.3960 −29.76% ▼ −7.77% −6.62% vs SPY
  2. Oct 6, 20265w ago Press Release Neutral 3/10 Entry $0.5720 to $0.5638 Now $0.3960 −30.77% ▼ −1.43% −1.29% vs SPY
  3. Sep 18, 20268w ago 8-K Neutral 3/10 Entry $0.6863 to $0.6211 Now $0.3960 −42.30% ▼ −9.50% −8.48% vs SPY
  4. Aug 14, 202613w ago 8-K Bearish 6/10 Entry $0.7564 to $0.6472 Now $0.3960 +47.65% ▲ +14.44% +13.07% vs SPY
  5. Aug 14, 202613w ago 424B5 Bearish 7/10 Entry $0.7564 to $0.6472 Now $0.3960 +47.65% ▲ +14.44% +13.07% vs SPY
  6. Aug 14, 202613w ago 8-K Bearish 6/10 No price data
  7. Aug 14, 202613w ago Press Release Mixed 7/10 Entry $0.7564 to $0.6472 Now $0.3960 −47.65% ▼ −14.44% −13.07% vs SPY
  8. Aug 12, 202613w ago Press Release Bearish 7/10 Entry $0.8888 to $0.6763 Now $0.3960 +55.45% ▲ +23.91% +21.94% vs SPY
  9. Aug 12, 202613w ago 8-K Bearish 7/10 Entry $0.8888 to $0.6763 Now $0.3960 +55.45% ▲ +23.91% +21.94% vs SPY
  10. Jul 24, 202616w ago 8-K Bullish 8/10 Entry $1.07 to $0.9766 Now $0.3960 −62.82% ▼ −8.30% −9.37% vs SPY
Showing 10 of 37

US Market Status

Market Closed · Opens in 6h 29m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 3, 2026